Cargando…
Dihydroartemisinin Enhances Apo2L/TRAIL-Mediated Apoptosis in Pancreatic Cancer Cells via ROS-Mediated Up-Regulation of Death Receptor 5
BACKGROUND: Dihydroartemisinin (DHA), a semi-synthetic derivative of artemisinin, has recently shown antitumor activity in various cancer cells. Apo2 ligand or tumor necrosis factor-related apoptosis-inducing ligand (Apo2L/TRAIL) is regarded as a promising anticancer agent, but chemoresistance affec...
Autores principales: | Kong, Rui, Jia, Guang, Cheng, Zhuo-xin, Wang, Yong-wei, Mu, Ming, Wang, Shuang-jia, Pan, Shang-ha, Gao, Yue, Jiang, Hong-chi, Dong, De-li, Sun, Bei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364248/ https://www.ncbi.nlm.nih.gov/pubmed/22666346 http://dx.doi.org/10.1371/journal.pone.0037222 |
Ejemplares similares
-
Correction: Dihydroartemisinin Enhances Apo2L/TRAIL-Mediated Apoptosis in Pancreatic Cancer Cells via ROS-Mediated Up-Regulation of Death Receptor 5
por: Kong, Rui, et al.
Publicado: (2012) -
The activation of c-Jun NH(2)-terminal kinase is required for dihydroartemisinin-induced autophagy in pancreatic cancer cells
por: Jia, Guang, et al.
Publicado: (2014) -
H-Ras regulation of TRAIL death receptor mediated apoptosis
por: Chen, Jun-Jie, et al.
Publicado: (2014) -
Dihydroartemisinin-Transferrin Adducts Enhance TRAIL-Induced Apoptosis in Triple-Negative Breast Cancer in a P53-Independent and ROS-Dependent Manner
por: Zhou, Xinyu, et al.
Publicado: (2022) -
Thymoquinone Crosstalks with DR5 to Sensitize TRAIL Resistance and Stimulate ROS-Mediated Cancer Apoptosis
por: Abd-Rabou, Ahmed A, et al.
Publicado: (2021)